Publication:
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019

dc.contributor.authorGlobal Burden of Disease 2019 Cancer Collaboration
dc.contributor.authorCatalá-López, Ferrán
dc.contributor.funderBill & Melinda Gates Foundation
dc.contributor.funderAmerican Lebanese Syrian Associated Charities
dc.contributor.funderAmerican Lebanese Syrian Associated Charitieses_ES
dc.contributor.funderKuwait University (Kuwait)es_ES
dc.contributor.funderNational University of Malaysia (Malasia)es_ES
dc.contributor.funderAlexander von Humboldt Foundation
dc.contributor.funderFederal Ministry of Education & Research (Alemania)
dc.contributor.funderNIH - National Cancer Institute (NCI) (Estados Unidos)es_ES
dc.contributor.funderNIH - National Cancer Institute (NCI) (Estados Unidos)
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)
dc.contributor.funderUnión Europea. Comisión Europea. H2020
dc.contributor.funderNovo Nordisk Foundation
dc.contributor.funderNational Health and Medical Research Council (Australia)
dc.contributor.funderJazan University (Arabia Saudí)es_ES
dc.contributor.funderRomanian National Authority for Scientific Research and Innovationes_ES
dc.contributor.funderMinistry of Education (Brasil)es_ES
dc.contributor.funderNational Heart Foundation of Australiaes_ES
dc.contributor.funderMinistry of Education, Science and Technological Development (Serbia)
dc.contributor.funderNHS - Research Scotland (Reino Unido)es_ES
dc.contributor.funderMedical Research Council (Reino Unido)
dc.contributor.funderScottish Government (Reino Unido)es_ES
dc.contributor.funderJatiya Kabi Kazi Nazrul Islam University (Bangladesh)es_ES
dc.contributor.funderXiamen University Malaysia (Malasia)es_ES
dc.contributor.funderManipal Academy of Higher Education (India)es_ES
dc.contributor.funderSistema Nacional de Investigación (Panamá)es_ES
dc.contributor.funderSecretaría Nacional de Ciencia, Tecnología e Innovación (Panamá)
dc.contributor.funderKing College London
dc.contributor.funderNational Health Service (Reino Unido)
dc.contributor.funderGovernment of the Russian Federationes_ES
dc.contributor.funderCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (Brasil)
dc.contributor.funderNational Council for Scientific and Technological Development (Brasil)
dc.contributor.funderCancer Prevention and Research Institute of Texas (Estados Unidos)
dc.contributor.funderNational Health and Medical Research Council (Australia)
dc.contributor.funderFundação para a Ciência e Tecnologia (Portugal)
dc.date.accessioned2023-05-03T11:21:45Z
dc.date.available2023-05-03T11:21:45Z
dc.date.issued2022-03
dc.description.abstractImportance: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. Objective: To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. Evidence review: The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs). Findings: In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles. Conclusions and relevance: The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThe Institute for Health Metrics and Evaluation received funding from the Bill & Melinda Gates Foundation and the American Lebanese Syrian Associated Charities. Dr Aljunid acknowledges the Department of Health Policy and Management of Kuwait University and the International Centre for Casemix and Clinical Coding, National University of Malaysia for the approval and support to participate in this research project. Dr Bhaskar acknowledges institutional support from the NSW Ministry of Health and NSW Health Pathology. Dr Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, which is funded by the German Federal Ministry of Education and Research. Dr Braithwaite acknowledges funding from the National Institutes of Health/ National Cancer Institute. Dr Conde acknowledges financial support from the European Research Council ERC Starting Grant agreement No 848325. Dr Costa acknowledges her grant (SFRH/BHD/110001/2015), received by Portuguese national funds through Fundação para a Ciência e Tecnologia, IP under the Norma Transitória grant DL57/2016/CP1334/CT0006. Dr Ghith acknowledges support from a grant from Novo Nordisk Foundation (NNF16OC0021856). Dr Glasbey is supported by a National Institute of Health Research Doctoral Research Fellowship. Dr Vivek Kumar Gupta acknowledges funding support from National Health and Medical Research Council Australia. Dr Haque thanks Jazan University, Saudi Arabia for providing access to the Saudi Digital Library for this research study. Drs Herteliu, Pana, and Ausloos are partially supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDI, project number PN-III-P4-ID-PCCF-2016-0084. Dr Hugo received support from the Higher Education Improvement Coordination of the Brazilian Ministry of Education for a sabbatical period at the Institute for Health Metrics and Evaluation, between September 2019 and August 2020. Dr Sheikh Mohammed Shariful Islam acknowledges funding by a National Heart Foundation of Australia Fellowship and National Health and Medical Research Council Emerging Leadership Fellowship. Dr Jakovljevic acknowledges support through grant OI 175014 of the Ministry of Education Science and Technological Development of the Republic of Serbia. Dr Katikireddi acknowledges funding from a NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and the Scottish Government Chief Scientist Office (SPHSU17). Dr Md Nuruzzaman Khan acknowledges the support of Jatiya Kabi Kazi Nazrul Islam University, Bangladesh. Dr Yun Jin Kim was supported by the Research Management Centre, Xiamen University Malaysia (XMUMRF/2020-C6/ITCM/0004). Dr Koulmane Laxminarayana acknowledges institutional support from Manipal Academy of Higher Education. Dr Landires is a member of the Sistema Nacional de Investigación, which is supported by Panama’s Secretaría Nacional de Ciencia, Tecnología e Innovación. Dr Loureiro was supported by national funds through Fundação para a Ciência e Tecnologia under the Scientific Employment Stimulus–Institutional Call (CEECINST/00049/2018). Dr Molokhia is supported by the National Institute for Health Research Biomedical Research Center at Guy’s and St Thomas’ National Health Service Foundation Trust and King’s College London. Dr Moosavi appreciates NIGEB's support. Dr Pati acknowledges support from the SIAN Institute, Association for Biodiversity Conservation & Research. Dr Rakovac acknowledges a grant from the government of the Russian Federation in the context ofWorld Health Organization Noncommunicable Diseases Office. Dr Samy was supported by a fellowship from the Egyptian Fulbright Mission Program. Dr Sheikh acknowledges support from Health Data Research UK. Drs Adithi Shetty and Unnikrishnan acknowledge support given by Kasturba Medical College, Mangalore, Manipal Academy of Higher Education. Dr Pavanchand H. Shetty acknowledges Manipal Academy of Higher Education for their research support. Dr Diego Augusto Santos Silva was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil Finance Code 001 and is supported in part by CNPq (302028/2018-8). Dr Zhu acknowledges the Cancer Prevention and Research Institute of Texas grant RP210042.es_ES
dc.format.number3es_ES
dc.format.page420-444es_ES
dc.format.volume8es_ES
dc.identifier.citationJAMA Oncol. 2022 Mar 1;8(3):420-444.es_ES
dc.identifier.doi10.1001/jamaoncol.2021.6987es_ES
dc.identifier.e-issn2374-2445es_ES
dc.identifier.journalJAMA oncologyes_ES
dc.identifier.pubmedID34967848es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15945
dc.language.isoenges_ES
dc.publisherAmerican Medical Associationes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/848325/EUes_ES
dc.relation.publisherversionhttps://doi.org/10.1001/jamaoncol.2021.6987es_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidad (ENS)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshGlobal Burden of Diseasees_ES
dc.subject.meshNeoplasmses_ES
dc.subject.meshDisability-Adjusted Life Yearses_ES
dc.subject.meshGlobal Healthes_ES
dc.subject.meshHumanses_ES
dc.subject.meshIncidencees_ES
dc.subject.meshPrevalencees_ES
dc.subject.meshQuality-Adjusted Life Yearses_ES
dc.subject.meshRisk Factorses_ES
dc.titleCancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019es_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationc2e7abf4-ef1a-414b-8ad5-def093def943
relation.isAuthorOfPublication.latestForDiscoveryc2e7abf4-ef1a-414b-8ad5-def093def943
relation.isFunderOfPublication7f469bdd-6b2f-4fa0-8d02-d769f14a04f5
relation.isFunderOfPublication829aa4f0-b765-438f-a7f4-cc01364fef59
relation.isFunderOfPublication84ee9531-f8a6-43c2-9fd3-be487dceb1a8
relation.isFunderOfPublication97344c05-e1d0-4912-afce-7075433a6768
relation.isFunderOfPublicationb589134c-ce3e-4f64-a3f5-83d0a7eb706a
relation.isFunderOfPublicationcb2ee04a-8d42-4a64-b3f6-3c156f222b35
relation.isFunderOfPublicationa418cf3b-f427-4376-a75f-01dba9bb944f
relation.isFunderOfPublication580699ab-1a17-49e9-9d2f-df57820bdf05
relation.isFunderOfPublication6b943834-3cee-4945-92d4-3b5185fabe72
relation.isFunderOfPublicationbdf25daf-5e9d-4d65-b03f-272ebafed830
relation.isFunderOfPublication0a2c122a-0ea9-4e9e-a57a-35e632489fa3
relation.isFunderOfPublication1ef12bf3-37e5-4475-9523-eae68ea2c7d6
relation.isFunderOfPublication91d53fef-2ae0-4d37-bd1e-99e6a08aa395
relation.isFunderOfPublicationd7c8932f-8892-4323-a3ed-fc0c07e9644e
relation.isFunderOfPublication2e9f1e86-99e6-4fb8-a07e-fa8dff5e18e2
relation.isFunderOfPublication390e20ab-06a3-4274-8b0e-7c50e2cf32eb
relation.isFunderOfPublicationfc67ceba-6d0b-45d3-a986-2a0257e544d3
relation.isFunderOfPublication25f151af-8d71-4e41-b920-ca8474d267b7
relation.isFunderOfPublication.latestForDiscovery7f469bdd-6b2f-4fa0-8d02-d769f14a04f5

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CancerIncidenceMortalityYears_2022.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format
Description: